<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17  PATIENT COUNSELING INFORMATION<BR>               <BR>                  See <BR>                        FDA-Approved Patient Labeling (17.2)<BR>                     .<BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.1 Information for Patients<BR>                     <BR>                        Patients should be informed that antimuscarinic agents such as DETROL LA may produce the following effects: blurred vision, dizziness, or drowsiness. Patients should be advised to exercise caution in decisions to engage in potentially dangerous activities until the drug's effects have been determined.<BR>                     <BR>                     <BR>                  <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     17.2  FDA-Approved Patient Labeling<BR>                     <BR>                        <BR>                           <BR>                        <BR>                        LAB-0256-8.0<BR>September 2011<BR>                     <BR>                     <BR>                     <BR>                        <BR>                           Logo<BR>                           <BR>                              <BR>                           <BR>                        <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>